Jaguar Health (JAGX) Net Cash Flow (QoQ) (2014 - 2026)
Jaguar Health (JAGX) Net Cash Flow (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,774.59 Bn | 1,774.53 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.53 Bn | 468.74 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.91 Bn | 116.66 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.79 Bn | 63.04 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.75 Bn | 49.57 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.10 Bn | 35.10 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.11 Bn | 36.11 Bn | - |
| 10 | Jaguar Health | 509,443.80 | -9.55 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -48.67% |
| Dec 31, 2025 | 174.84% |
| Sep 30, 2025 | 144.35% |
| Jun 30, 2025 | -50.77% |
| Mar 31, 2025 | 54.94% |
| Dec 31, 2024 | -85.38% |
| Sep 30, 2024 | -163.83% |
| Jun 30, 2024 | -15.65% |
| Mar 31, 2024 | 63.21% |
| Dec 31, 2023 | 159.45% |
| Sep 30, 2023 | 5.58% |
| Jun 30, 2023 | -164.28% |
| Mar 31, 2023 | 272.29% |
| Dec 31, 2022 | -429.45% |
| Sep 30, 2022 | 121.66% |
| Jun 30, 2022 | -1,684.84% |
| Mar 31, 2022 | -90.27% |
| Dec 31, 2021 | 123.93% |
| Sep 30, 2021 | -5,784.64% |
| Jun 30, 2021 | -101.37% |